Navigation Links
Visage Imaging and Agfa Healthcare Sign Worldwide Agreement to Integrate Visage Offerings to the IMPAX(TM) Suites
Date:11/26/2007

For more information on Agfa HealthCare, please visit http://www.agfa.com/healthcare.

Visage Imaging, Inc. - Visioneering Science for Life

Visage Imaging, Inc. designs and engineers clinical products that present its customers with the ability to overcome demanding market challenges and improve diagnostic results with accuracy and expedience. As a wholly owned subsidiary of Mercury Computer Systems, Inc., Visage Imaging incorporates Mercury's 20 years of technical expertise and deep knowledge of the science behind diagnostic applications into its practice. Visage Imaging leverages this experience to push the boundaries of what is possible within its domain.

Through collaborative learning, Visage Imaging has built a nimble, creative organization: one that is first to market with innovative 3D clinical applications, and offers best-in-class 3D products that are unique, reliable, and help its customers accelerate their own market innovation and clinical benefit.

For more, see http://www.visageimaging.com

Forward-Looking Safe Harbor Statement

This press release contains certain forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995, including those relating to Visage Imaging, Inc.'s product line and 3D to the Core solutions. You can identify these statements by our use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. These forward- looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. Such risks and uncertainties include, but are not limited to, general economic and business conditions, including unforeseen weakness in Visage Imaging's markets, effects of continued geo-political unr
'/>"/>

SOURCE Mercury Computer Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Brain imaging reveals breakdown of normal emotional processing
2. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
3. Fry Construction Selected for High-Profile Medical Imaging Project
4. Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel
5. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
6. Imaging Software Helps Track, Treat Injured Brains
7. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
8. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
9. Revision: Ziehm Imaging and BrainLAB Announce Partnership for Intra-Operative 3D Imaging and Computer Assisted Surgery (CAS)
10. Brain Imaging Expert Recruited to Study Autism at The Childrens Hospital of Philadelphia
11. Medical Imaging Revolutionizes Modern Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)...ewswire/ -- Governor Edward,G. Rendell today said ...,with high fuel costs and a broken healthcare syst...ergy independence and make healthcare more,afforda...ed to hear the Governor,s message at the,Governmen...nsylvania,s,largest outdoor agricultural expositio...
(Date:8/20/2008)...art of a new generation of neurosurgeons who are m...At Loyola University Hospital, Duckworth is using ...ir life-threatening aneurysms and to dramatically ...han removing large sections of the skull or face, ...er openings. And in certain cases, he goes through...
(Date:8/20/2008).../ -- Yesterday evening,Congresswoman Stephanie Tu...fering an aneurysm while driving her car in Clevel...Jones, condition has stabilized and she is,receivi...followed a full day of activity, including plannin...uled for September 4, 2008,at Cleveland State Univ...
(Date:8/20/2008)...alth technologies designed to,monitor and care for...s in,excess of $1.8 billion by 2013., Technologic...hardware,revenues, according to Parks Associates, ...ogies. Connected medical, activity, and environmen...ring in more than twice the,dollar amount of the l...
Breaking Medicine News(10 mins):Health News:Pennsylvania Governor Rendell Highlights Renewable Energy, Health Care Reform at Ag Progress Days 2Health News:Brain surgery is getting easier on patients 2Health News:Brain surgery is getting easier on patients 3Health News:Service and Hardware Revenues Will Contribute $1.8 Billion to the U.S. Eldercare Industry by 2013 2
...entists warn that passive smokings from cigarette ...entists have now detected the cancer-causing chemi...in the urine of nearly half the babies whose paren...e message is, 'Don't smoke around your kids,'" sai...
...tudy states that the organ donation rate in UK is ...ieving relatives are reluctant to allow such proce...re blocking the wishes of potential organ donors b...d about what their loved-ones would have wanted, c...
.... health officials suspect the abortion pill, RU-4...erial infections. //Out of the 6 women who took th...or RU-486 is now expected to be pulled from the sh...ibuted their deaths to the drug. The rare bacteriu...
...ording to a recent study conducted by the research...as found that one in seven East Asian immigrants a...ispose them to conditions such as liver cancer and...t of the people are unaware that they were infecte...
Other Medicine News:Health News:Cancer Causing Chemicals Found In Urine Of Babies Whose Parents Smoke 2Health News:Grieving Relatives Reluctant To Give Consent For Organ Donation 2Health News:East Asian Immigrants Bring Hepatitis to New York 2
(Date:8/14/2008)...INGAPORE, Aug. 15 /- AstraZ...new partnership with the National Cancer,Centre Si...l (NUH) to,develop anti-cancer compounds. The coll...nderstanding (MOU) that was signed today, aims to ...ilities in Asia and ultimately,speed up access to ...
(Date:8/14/2008)...st T cell engaging antibody (BiTE) showing clinica... patients own T cells to recognize and attack ...Md., Aug. 14 /- Micromet, I...developing novel, proprietary,antibodies for the t...seases, today announced publication of a Phase 1 c...
(Date:8/14/2008)... - Phase 2 development to begin in late 2008 or i...wswire-FirstCall/ -- Nuvelo, Inc.,(Nasdaq: NUVO )...b,proof-of-concept trial of NU172, demonstrating t... and maintained anticoagulation with a rapid,retur...favorable safety,profile., "NU172 has the potenti...
(Date:8/13/2008)...igh Omega-3 Fat Intake Improves Insulin Sensitivit...lter Endocrine Responsiveness, PHOENIX, Aug. 13 /...enix-based Kronos Longevity Research Institute (KL... insulin sensitivity and reduces inflammatory,mark...This study was,recently published in Hormones and ...
Breaking Medicine Technology:AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 2AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 5AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 6Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 2Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 3Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 4Study Shows Benefits of a High Omega-3 Diet in Older Adults 2Study Shows Benefits of a High Omega-3 Diet in Older Adults 3Biophysical Society announces winners of 2008 Minority Travel Awards 1714 1Biophysical Society announces winners of 2008 Minority Travel Awards 1714 2Kids in Poor Neighborhoods Fall Behind in School 8726 1Kids in Poor Neighborhoods Fall Behind in School 8726 2Songbirds offer clues to highly practiced motor skills in humans 8724 1Songbirds offer clues to highly practiced motor skills in humans 8724 2Songbirds offer clues to highly practiced motor skills in humans 8724 3Gerresheimer Expands its Pharmaceutical Plastic Operations Into Southern Europe and South America 8720 1Gerresheimer Expands its Pharmaceutical Plastic Operations Into Southern Europe and South America 8720 2
...ed at the Congress of the European Hematology,Asso...tCall/ -- Favrille,Inc. , a biopharmaceutical com...rapies for the treatment of cancer, announced,inte... in patients,with indolent B-cell non-Hodgkin,s ly...ss of the European Hematology Association in,Vienn...
...stria, June 11, 2007 /PRNewswire/ -- GlaxoSmithKli...votal Phase III,study of its investigational non-p...ltrombopag olamine). Data from this study,showed t...tatistically significant increase in platelet coun...h chronic idiopathic,thrombocytopenic purpura (ITP...
Other Medicine Technology:Favrille Announces Data From Phase 2 Clinical Trial of FavId for,Indolent B-Cell Non-Hodgkin's Lymphoma in Europe 2Favrille Announces Data From Phase 2 Clinical Trial of FavId for,Indolent B-Cell Non-Hodgkin's Lymphoma in Europe 3Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 2Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 3Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 4Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 5Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 6
Heine Beta 200 Streak Retinoscope 3.5v w/Twist Lock for Welch-Allyn style handles.
Heine Beta 200 Streak Retinoscope 3.5v
Video Equipment
Micro-mini fiber optic light.
Medicine Products: